Aducanumab is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some prominent experts say there’s not enough evidence it can address cognitive symptoms.
Top Lifestyle Trends for 2025: What’s Shaping the Future of How We Live
As we step into 2025, the world is witnessing a rapidly evolving landscape of lifestyle choices and trends. With technology advancing at an unprecedented pace,